Sarepta Therapeutics, Inc. (LON:0L35)
London · Delayed Price · Currency is GBP · Price in USD 17.66
-0.43 (-2.36%)
At close: Sep 17, 2025
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 1.22 billion as of September 18, 2025. Its market cap has decreased by -87.74% in one year.
Market Cap
1.22B
Enterprise Value
1.63B
Revenue
1.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.66
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 43.06M to 1.22B, an increase of 2,731.88%. That is a compound annual growth rate of 12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 1.30B | -86.03% |
| Dec 31, 2024 | 9.28B | 31.00% |
| Dec 29, 2023 | 7.08B | -24.98% |
| Dec 30, 2022 | 9.44B | 63.02% |
| Dec 31, 2021 | 5.79B | -41.23% |
| Dec 31, 2020 | 9.85B | 35.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| GSK plc | 59.31B |
| Haleon | 30.40B |
| Smith & Nephew | 11.87B |
| ConvaTec Group | 4.76B |
| Hikma Pharmaceuticals | 3.58B |
| HUTCHMED (China) | 2.18B |
| Genus | 1.65B |